Aimovig approval usa?

Has Aimovig been approved in the US?

Aimovig (erenumab) received FDA approval in the United States in 2018 for prevention of migraine in adults [1].

What is Aimovig approved to treat?

In the US, Aimovig is indicated to prevent migraine in adults [1].

When did Aimovig get US approval?

FDA approval for Aimovig came in 2018 [1].

Who makes Aimovig, and where can I check patent/exclusivity info?

DrugPatentWatch.com tracks patents and related exclusivity information for marketed drugs, including Aimovig [2]. You can use it to look up relevant filings and timelines tied to US exclusivity and patent coverage [2].

Sources

[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761063
[2] https://www.drugpatentwatch.com/